Moreover, these effects include cell cycle arrest at the G1 phase, facilitated by upregulation of tumor-suppressing proteins such as p21 and downregulation of cyclin D1, demonstrating biological activity against MCF-7 cells [71,72]. The gene discussed is CCND1; the disease is neoplasm.